Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details)

v3.19.2
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Aug. 03, 2019
Aug. 04, 2018
Aug. 03, 2019
Aug. 04, 2018
Cash flows from operating activities:        
Net income (loss) $ 86 $ 164 $ 223 $ 296
Impairment and other costs 2 17 3 36
Settlement charges 0 50 0 50
Equity in loss (earnings) of subsidiaries 0 0 0 0
Dividends received from subsidiaries     0 0
Depreciation and amortization     472 470
Gains on sale of real estate (7) (46) (49) (70)
Change in assets, liabilities and other items not separately identified     (299) (238)
Net cash provided by operating activities     350 544
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     (442) (320)
Other, net     (12) 8
Net cash used by investing activities     (454) (312)
Cash flows from financing activities:        
Debt repaid     (39) (357)
Debt repaid, including debt issuance costs     (42)  
Dividends paid     (233) (232)
Issuance of common stock     6 38
Proceeds from noncontrolling interest     0 5
Intercompany activity, net     0 0
Other, net     (128) (90)
Net cash provided (used) by financing activities     (397) (636)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     (501) (404)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     1,248 1,513
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 747 1,109 747 1,109
Parent        
Cash flows from operating activities:        
Net income (loss) 86 166 223 306
Impairment and other costs 0 0 0 0
Settlement charges   6 0 6
Equity in loss (earnings) of subsidiaries (82) (167) (214) (304)
Dividends received from subsidiaries     606 492
Depreciation and amortization     0 0
Gains on sale of real estate 0 0 0 0
Change in assets, liabilities and other items not separately identified     (52) (154)
Net cash provided by operating activities     563 346
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     0 0
Other, net     0 0
Net cash used by investing activities     0 0
Cash flows from financing activities:        
Debt repaid       0
Debt repaid, including debt issuance costs     0  
Dividends paid     (233) (232)
Issuance of common stock     6 38
Proceeds from noncontrolling interest       0
Intercompany activity, net     (813) (441)
Other, net     (92) (76)
Net cash provided (used) by financing activities     (1,132) (711)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     (569) (365)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     889 1,109
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 320 744 320 744
Subsidiary Issuer        
Cash flows from operating activities:        
Net income (loss) (164) (52) (207) (122)
Impairment and other costs 0 (2) 0 (2)
Settlement charges   16 0 16
Equity in loss (earnings) of subsidiaries 108 (8) 138 (109)
Dividends received from subsidiaries     0 0
Depreciation and amortization     169 165
Gains on sale of real estate 0 (19) (24) (42)
Change in assets, liabilities and other items not separately identified     47 298
Net cash provided by operating activities     123 204
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     (97) (49)
Other, net     (11) (15)
Net cash used by investing activities     (108) (64)
Cash flows from financing activities:        
Debt repaid       (306)
Debt repaid, including debt issuance costs     (42)  
Dividends paid     0 0
Issuance of common stock     0 0
Proceeds from noncontrolling interest       0
Intercompany activity, net     93 162
Other, net     (21) (9)
Net cash provided (used) by financing activities     30 (153)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     45 (13)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     64 79
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 109 66 109 66
Other Subsidiaries        
Cash flows from operating activities:        
Net income (loss) 138 225 283 525
Impairment and other costs 2 19 3 38
Settlement charges   28 0 28
Equity in loss (earnings) of subsidiaries 0 0 0 0
Dividends received from subsidiaries     0 0
Depreciation and amortization     303 305
Gains on sale of real estate (7) (27) (25) (28)
Change in assets, liabilities and other items not separately identified     (294) (381)
Net cash provided by operating activities     270 487
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     (345) (271)
Other, net     (1) (28)
Net cash used by investing activities     (346) (299)
Cash flows from financing activities:        
Debt repaid       (1)
Debt repaid, including debt issuance costs     0  
Dividends paid     (606) (492)
Issuance of common stock     0 0
Proceeds from noncontrolling interest       5
Intercompany activity, net     720 279
Other, net     (15) (5)
Net cash provided (used) by financing activities     99 (214)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     23 (26)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     295 325
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 318 299 318 299
Consolidating Adjustments        
Cash flows from operating activities:        
Net income (loss) 26 (175) (76) (413)
Impairment and other costs 0 0 0 0
Settlement charges   0 0 0
Equity in loss (earnings) of subsidiaries (26) 175 76 413
Dividends received from subsidiaries     (606) (492)
Depreciation and amortization     0 0
Gains on sale of real estate 0 0 0 0
Change in assets, liabilities and other items not separately identified     0 (1)
Net cash provided by operating activities     (606) (493)
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     0 0
Other, net     0 51
Net cash used by investing activities     0 51
Cash flows from financing activities:        
Debt repaid       (50)
Debt repaid, including debt issuance costs     0  
Dividends paid     606 492
Issuance of common stock     0 0
Proceeds from noncontrolling interest       0
Intercompany activity, net     0 0
Other, net     0 0
Net cash provided (used) by financing activities     606 442
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period $ 0 $ 0 $ 0 $ 0